Telomir Pharmaceuticals, Inc. (TELO)

NASDAQ: TELO · Real-Time Price · USD

1.080

+0.020 (1.89%)

At close: Aug 18, 2026, 4:00 PM EDT

1.090

+0.010 (0.93%)

After-hours: Aug 18, 2026, 4:58 PM EDT

Telomir Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.17	7.29	1.27	0	0	-
Cash & Short-Term Investments	5.17	7.29	1.27	0	0	-
Cash Growth	585.42%	475.51%	102753.86%	-13.25%	-	-
Prepaid Expenses	0.2	0.05	0.06	0	-	-
Other Current Assets	-	-	-	0.43	0.05	-
Total Current Assets	5.37	7.34	1.32	0.44	0.05	-
Long-Term Deferred Charges	-	-	-	4.34	-	-
Total Assets	5.37	7.34	1.32	4.77	0.05	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.2	0.54	0.59	0.71	0.4	0.02
Accrued Expenses	-	0.42	-	-	-	-
Short-Term Debt	0.14	0.47	0.09	0.63	0.58	0.12
Total Current Liabilities	0.33	1.43	0.68	1.34	0.99	0.14
Total Liabilities	0.33	1.43	0.68	1.34	0.99	0.14

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Additional Paid-In Capital	48.76	46.92	31.24	17.5	0.06	0.06
Retained Earnings	-43.72	-41.01	-30.6	-14.06	-0.99	-0.14
Comprehensive Income & Other	-	-	-	-	-	-0.06
Shareholders' Equity	5.03	5.91	0.64	3.44	-0.94	-0.14
Total Liabilities & Equity	5.37	7.34	1.32	4.77	0.05	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.14	0.47	0.09	0.63	0.58	0.12
Net Cash (Debt)	5.03	6.81	1.17	-0.63	-0.58	-0.12
Net Cash Growth	661.61%	480.96%	-	-	-	-
Net Cash Per Share	0.12	0.22	0.04	-0.02	-0.02	-
Filing Date Shares Outstanding	68.77	34.38	29.76	29.61	27.1	-
Total Common Shares Outstanding	68.77	34.38	29.76	28.61	26.83	-
Working Capital	5.03	5.91	0.64	-0.9	-0.94	-0.14
Book Value Per Share	0.07	0.17	0.02	0.12	-0.03	-
Tangible Book Value	5.03	5.91	0.64	3.44	-0.94	-0.14
Tangible Book Value Per Share	0.07	0.17	0.02	0.12	-0.03	-

SEC Filings: 10-K · 10-Q